De-novo COL4A5 gene mutations in Alport's syndrome

L. Massella, G. Rizzoni, R. De Blasis, P. Barsotti, T. Faraggiana, A. Renieri, M. Seri, L. Galli, M. De Marchi

Research output: Contribution to journalArticlepeer-review


Before the advent of direct molecular gene analysis the diagnosis of Alport syndrome was operationally based on three of the four classical clinical criteria. Recently, mutations have been identified in the COL4A5 gene, which is involved in X-linked Alport syndrome. Here we describe two de-novo mutations in two unrelated children, a male and a female, both with early onset of the nephropathy, but with only one of the diagnostic criteria, i.e. electron-microscopy alterations. Because of the significant estimated proportion of de-novo mutations this diagnosis should be considered in children with early signs of nephropathy, even without a suggestive family history or clinical picture (ocular or audiologic abnormalities). In the future the diagnosis of Alport syndrome will probably be made on the basis of both clinical findings and molecular analysis. Now Alport syndrome is clearly underdiagnosed.

Original languageEnglish
Pages (from-to)1408-1411
Number of pages4
JournalNephrology Dialysis Transplantation
Issue number10
Publication statusPublished - 1994


  • Alport syndrome
  • Hereditary nephritis

ASJC Scopus subject areas

  • Nephrology
  • Transplantation


Dive into the research topics of 'De-novo COL4A5 gene mutations in Alport's syndrome'. Together they form a unique fingerprint.

Cite this